Endopeptidase

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/57 (2006.01) C07K 14/46 (2006.01) C12N 9/64 (2006.01) C12P 21/00 (2006.01) C12P 21/06 (2006.01)

Patent

CA 2083702

2083702 9218516 PCTABS00016 There is provided by the invention a novel composition comprising, in at least partially purified form, an endopeptidase endogenous to biological cells. The endopeptidase is characterized by having a molecular weight of about 110,000 daltons as measured by SDS PAGE; by being substantially insensitive to PMSF, TPCK, E-64, leupeptin, bacitracin, phosphoramidon and pepstatin; by being substantially inhibited by EDTA and 1,10-phenanthroline; and by being capable of cleaving peptide substrate comprising an alpha helical structural of at least about twelve to fourteen amino acids wherein said helix has a hydrophobic face and a hydrophilic face, said cleavage occurring amino terminal to a lysine or arginine residue on the hydrophilic face positioned within the context of at least four nonpolar amino acids substantially aligned along the hydrophobic face of the helix.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Endopeptidase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endopeptidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endopeptidase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1573359

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.